Genetic variants of the apolipoprotein E (ApoE) gene have been associated with several neurodegenerative disorders including Alzheimer’s disease, cognitive impairment, and multiple sclerosis, as well as with varying rates of recovery from traumatic brain injury [1–3]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.